Skip to content

Effects of PlayStation®VR on the HRQOL in Stroke Patients Undergoing Inpatient Rehabilitation

Effects of PlayStation®VR on the Health-Related Quality of Life in Stroke Patients Undergoing Inpatient Rehabilitation: a Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04441177
Enrollment
80
Registered
2020-06-22
Start date
2019-07-29
Completion date
2021-06-30
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Virtual Reality, Rehabilitation

Brief summary

Compared to conventional rehabilitation therapy, the full-immersive commercial game (CG) system, in the form of available video game, could safely provide more positive effect on health-related quality of life (HRQOL) and motor function in post-stroke patients. The study aims to perform the research from 2019/7/1 to 2021/6/30 and enrolls a total of 80 participants. Stroke participants are recruited from the rehabilitation ward of CGMH hospital. The inclusion criteria are (a) first-time unilateral cerebral stroke, (b) stroke onset less or equal to 1 year, (c) admission to the rehabilitation ward, (d) ages 20-80 years, (e) spasticity of paretic arm ≤ grade 2 in the Modified Ashworth Scale, and (f) no active medical problems such as fever, pneumonia, or scabies. The exclusion criteria are (a) brainstem or cerebellar stroke, (b) epilepsy history, including photosensitive epilepsy, (c) previous or active heart diseases, such as myocardial infarction or angina, (d) visuospatial problems related to stroke, such as hemianopia or hemineglect, (e) paretic upper limb reaches Brunnstrom recovery stage VI, (f) severe aphasia, (g) severe cognitive impairment, and (h) poor cooperation with assessments. All participants are randomly allocated to study group and control group. Participants in the control group receive conventional rehabilitation therapy over 50 minutes on weekdays. Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period. Pre-intervention, post-intervention, and 3-month follow-up HRQOL will be assessed by the Stroke Impact Scale 3.0. Motricity Index and Fugl-Meyer Assessment, Functional Independence Measure, and arm movement ratio will also be checked before intervention, after intervention, and at 3-month follow-up. The safety outcome, intervention-related adverse events or any serious adverse events, during study period will be recorded.

Interventions

DEVICEPlayStation®VR training

Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Pre-intervention, post-intervention, and 3-month follow-up HRQOL will be assessed by the Stroke Impact Scale (SIS) 3.0. Motricity Index (MI) and Fugl-Meyer Assessment (FMA), Functional Independence Measure (FIM), and arm movement ratio (AMR) will also be checked before intervention, after intervention, and at 3-month follow-up. One blinded occupational therapist will evaluate the outcomes.

Intervention model description

All participants are randomly allocated to study group and control group. Each participant's main study period is set as 16 days with additional follow-up time at post-intervention 3 months. Participants in the control group receive conventional rehabilitation therapy over 50 minutes on weekdays. Participants in the study group receive conventional rehabilitation therapy over 50 minutes on weekdays and 7 sessions (flexible schedule in different day) of PlayStation®VR of 20 minutes each in the main 16-day study period.

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* first-time unilateral cerebral stroke * stroke onset less or equal to 1 year * admission to the rehabilitation ward * ages 20-80 years * spasticity of paretic arm ≤ grade 2 in the Modified Ashworth Scale * no active medical problems such as fever, pneumonia, or scabies

Exclusion criteria

* brainstem or cerebellar stroke * epilepsy history, including photosensitive epilepsy * previous or active heart diseases, such as myocardial infarction or angina * visuospatial problems related to stroke, such as hemianopia or hemineglect * paretic upper limb reaches Brunnstrom recovery stage VI * severe aphasia * severe cognitive impairment * poor cooperation with assessments

Design outcomes

Primary

MeasureTime frameDescription
Stroke Impact Scale (SIS) 3.0 QuestionnaireBaseline (Pre-intervention at 2 days after enrollment)Health-Related Quality of Life
Post-Intervention Change of Stroke Impact Scale (SIS) 3.0 QuestionnaireChange from baseline SIS scores at 18 days after enrollmentPost-intervention Health-Related Quality of Life
3-Month Follow-Up Change of Stroke Impact Scale (SIS) 3.0 QuestionnaireChange from baseline SIS scores at 92 days after enrollment3-month follow-up Health-Related Quality of Life
Post-Intervention of Adverse Events or SAE16 daysProportion of intervention-related adverse events or SAE

Secondary

MeasureTime frameDescription
Post-Intervention Change of Fugl-Meyer Assessment for Upper Extremity (FMA-UE)Change from baseline FMA-UE scores at 18 days after enrollmentPost-intervention motor impairment and function
3-Month Follow-Up Change of Fugl-Meyer Assessment for Upper Extremity (FMA-UE)Change from baseline FMA-UE scores at 92 days after enrollment3-month follow-up motor impairment and function
Self-Care in Functional Independence Measure (FIM) InstrumentBaseline (Pre-intervention) at 2 days after enrollmentThe FIM is an 18-item instrument measuring a person's level of disability in terms of burden of care in six areas including self-care, continence, mobility, transfers, communication, and cognition. Each of the 18 items is graded on a scale of 1-7 based on level of independence in that item (1 = total assistance required, 7 = complete independence). Six items (eating, grooming, bathing, dressing upper body, dressing lower body, and toileting) of self care will be scored and summed in this study.
Post-Intervention Change of Self-Care in Functional Independence Measure (FIM) InstrumentChange from baseline self-care scores at 18 days after enrollmentThe FIM is an 18-item instrument measuring a person's level of disability in terms of burden of care in six areas including self-care, continence, mobility, transfers, communication, and cognition. Each of the 18 items is graded on a scale of 1-7 based on level of independence in that item (1 = total assistance required, 7 = complete independence). Six items (eating, grooming, bathing, dressing upper body, dressing lower body, and toileting) of self care will be scored and summed in this study.
Motricity Index (MI) Upper Extremity TestBaseline (Pre-intervention) at 2 days after enrollmentMotor impairment and function
Arm Movement Ratio (AMR) TestBaseline (Pre-intervention) at 1 day after enrollmentThe AMR, the ratio of arm use duration between the more and less affected arm, is detected and calculated by an accelerometer. The participants are asked to wear one accelerometer (ActiGraph wGT3x-BT, ActiGraph, LLC., Pensacola, FL, USA) on each arm for 7 hours.
Post-Intervention Change of Arm Movement Ratio (AMR) TestChange from baseline AMR scores at 19 days after enrollmentThe AMR, the ratio of arm use duration between the more and less affected arm, is detected and calculated by an accelerometer. The participants are asked to wear one accelerometer (ActiGraph wGT3x-BT, ActiGraph, LLC., Pensacola, FL, USA) on each arm for 7 hours.
3-Month Follow-Up Change of Arm Movement Ratio (AMR) TestChange from baseline AMR scores at 93 days after enrollmentThe AMR, the ratio of arm use duration between the more and less affected arm, is detected and calculated by an accelerometer. The participants are asked to wear one accelerometer (ActiGraph wGT3x-BT, ActiGraph, LLC., Pensacola, FL, USA) on each arm for 7 hours.
3-Month Follow-Up Change of Self-Care in Functional Independence Measure (FIM) InstrumentChange from baseline self-care scores at 92 days after enrollmentThe FIM is an 18-item instrument measuring a person's level of disability in terms of burden of care in six areas including self-care, continence, mobility, transfers, communication, and cognition. Each of the 18 items is graded on a scale of 1-7 based on level of independence in that item (1 = total assistance required, 7 = complete independence). Six items (eating, grooming, bathing, dressing upper body, dressing lower body, and toileting) of self care will be scored and summed in this study.
Post-Intervention Change of Motricity Index (MI) Upper Extremity TestChange from baseline MI scores at 18 days after enrollmentPost-intervention motor impairment and function
3-Month Follow-Up Change of Motricity Index (MI) Upper Extremity TestChange from baseline MI scores at 92 days after enrollment3-month follow-up motor impairment and function
Fugl-Meyer Assessment for Upper Extremity (FMA-UE)Baseline (Pre-intervention) at 2 days after enrollmentMotor impairment and function

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026